News &amp; Updates

Individuals with potential chronic obstructive pulmonary disease (COPD) in the psychological and cachectic clusters appear to be at increased risk of mortality over 25 years of follow-up, according to a population-based Norwegian study. In addition, these clusters appear to increase the risk of severe COPD exacerbations.

31 Mar 2022

Ebbs and flows in weight influence CVD risk in T2D patients

In individuals with type 2 diabetes (T2D), greater variability in adiposity indices (BMI and waist circumference [WC]) was tied to increased risk of cardiovascular disease (CVD) outcomes and death – but an intensive weight loss programme mitigated this risk, a study suggests.

31 Mar 2022

Robotic exoskeleton helps with mobilization in patients with heart failure

The use of a robotic exoskeleton is a feasible intervention to assist mobilization in patients with advanced heart failure, according to a recent study.

31 Mar 2022

Spells, tremors common among infants with vitamin B12 deficiency

Infants with early vitamin B12 deficiency commonly show signs of spells, tremors, and irritability, a new study has found. The administration of nitrous oxide during labour appears to be a risk factor for such deficiency in neonates.

Low-dose aspirin prevents common GI cancers in Chinese adults without ASCVD

Low-dose aspirin reduces risks of some common gastrointestinal (GI) cancers, including colorectal cancer (CRC) and gastric cancer (GC), in Chinese without atherosclerotic cardiovascular disease (ASCVD), compared with paracetamol, the first population-wide study from the University of Hong Kong (HKU) has shown.

31 Mar 2022

Benralizumab reduces asthma exacerbation rates in real-world setting

Treatment with benralizumab significantly reduces exacerbation rates in patients with asthma in a real-world setting, according to the ZEPHYR 2 study presented at AAAAI 2022.

Traumatic experiences implicated in CVD risk in women

Interpersonal violence, such as childhood abuse and intimate partner violence, is associated with a heightened risk of developing cardiovascular disease (CVD) in women, according to a study.

Tezepelumab cuts asthma attacks in patients with severe asthma across seasons

30 Mar 2022 by

Not only does tezepelumab reduce asthma symptomatic days, it prevents asthma exacerbations across all seasons in adolescents and adults with severe, uncontrolled asthma, according to the prespecified exploratory analyses of the NAVIGATOR trial presented at AAAAI 2022.

Older critical illness survivors with dual eligibility at risk of functional, cognitive decline

Functional and cognitive decline after an intensive care unit (ICU) hospitalization appears to occur more frequently among dual-eligible older persons than their more advantaged counterparts, reports a study.